By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

A New Biomarker Emerges for Stroke Risk in Diabetic Patients

From Yeast to Humans: The Deep Evolutionary Roots of RNA Quality Control

A New Lens on Population Counts: Bayesian Models Refine Parental Abundance Estimates

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Oncology - The Power of Expectation: A Non-Deceptive Path to Reducing Treatment Side Effects

Oncology

The Power of Expectation: A Non-Deceptive Path to Reducing Treatment Side Effects

Last updated: March 24, 2026 1:06 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE

The Power of Expectation: A Non-Deceptive Path to Reducing Treatment Side Effects

A new study published in the European Journal of Pain investigates a promising, ethical strategy to mitigate nocebo effects—the phenomenon where negative expectations worsen symptoms like pain. Researchers tested whether “counterconditioning,” a learning-based technique, could reduce conditioned nocebo effects on pressure pain in healthy participants. The trial compared open-label (fully transparent) and closed-label (deceptive) counterconditioning against a standard extinction procedure. Results showed that while all three methods significantly reduced nocebo effects, open-label counterconditioning was the most effective. It not only reversed the negative expectation but also induced a positive placebo effect, demonstrating that patients can be honestly guided to reframe their anticipations without deception.

Study Significance: For professionals in oncology and cancer care, this research on nocebo reduction is directly applicable to managing the side effects of treatments like chemotherapy and radiotherapy. It offers a concrete, non-deceptive method to potentially improve patient quality of life by ethically reshaping negative expectations associated with therapy. Integrating such open-label psychological strategies into supportive care protocols could help mitigate anticipatory nausea, fatigue, and pain, thereby enhancing treatment adherence and survivorship outcomes.

Source →

Stay curious. Stay informed — with Science Briefing.

Always double check the original article for accuracy.

- Advertisement -

Feedback

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article How Harsh Winters Shape a Squirrel’s Hoarding Instinct
Next Article A Meta-Analysis Maps Patient Traits to Postoperative Pain and Opioid Risk
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

A new platform for predicting drug toxicity after liver metabolism

A New Immunological Culprit in Uterus Transplant Complications

Unmasking a New Pathway of Resistance in Ovarian Cancer

Tumour DNA Holds the Key to Classifying Hereditary Cancer Risk

A Prescription for Prediction: Drug Patterns Signal ALS Years Before Diagnosis

A new driver of breast cancer emerges from the nucleus

Correction to: A distinct lung cancer subtype defined by dual biomarker expression

Editorial Board

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Social Sciences
  • Gastroenterology
  • Surgery
  • Natural Language Processing
  • Cell Biology
  • Engineering
  • Genetics
  • Immunology

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?